Notably, CD300E is upregulated in cancers such as Myeloma, Diffuse Large B-cell Lymphoma, Ovarian Cancer, Lung Cancer, and Colorectal Cancer, suggesting its involvement in the progression of these diseases. This evidence concerns the gene CD300E and lung cancer.